Skip to main content

Save up to 20% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 20% on print and eBooks.

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A

1st Edition, Volume 381 - September 19, 2023

Editors: Carolina Reduzzi, Lorenzo Gerratana, Massimo Cristofanilli

Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 1 6 1 3 4 - 6
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 1 6 1 3 5 - 3

"Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of ci… Read more

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

"Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast, prostate, colorectal and lung cancer, with a focus on clinical utility, and also include methodological and biological topics such as CTC culture, multi-omic characterization of CTCs, atypical CTC populations and interaction between CTCs and immunity.